An international group of scientist have successfully used a technique that allows scientists to make precise changes to genomes with relative ease called CRISPER-Cas 9. The study was first published in online in Nature journal.
Researchers used a mutation in a gene called MYBPC3, which causes the heart muscle to thicken — a condition known as hypertrophic cardiomyopathy. They injected CRISPR-Cas 9 into 54 embryos and after a few days found that 42 or 72.4 percent of the embryos were free of the mutation without any negative side effects.
The researchers speculate that this technology could be used to help families plagued with genetic disease.
This technology is still far from clinical testing.
Opponents of the research argue the ethnics and fear the technology would be used to make designer babies.